From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial
FAS
PPS
IFNα1b Group
Control Group
Use of Item antibiotics
5 (6.6%)
8 (9.2%)
5 (7.2%)
7 (8.5%)
Use of antibiotics
71 (93.4%)
79 (90.8%)
64 (92.8%)
75 (91.5%)
P
0.745
1.000